SCHEMBL27354943

SCHEMBL27354943

O=C(O)c1cccn(C2CCC(F)(F)CC2)c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 9/20 0.43
▸ PARP2 Q9UGN5 4/20 0.43
▸ DHODH Q02127 3/20 0.37
▸ KDM4E B2RXH2 3/20 0.36
▸ HSD17B10 Q99714 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ TEAD1 P28347 1/20 0.34
▸ TEAD4 Q15561 1/20 0.34
▸ TEAD2 Q15562 1/20 0.34
▸ KDM5A P29375 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ KDM5B Q9UGL1 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2B6 P20813 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.34
▸ TLR8 Q9NR97 1/20 0.34
▸ TLR7 Q9NYK1 1/20 0.34
▸ AKT1 P31749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27354751 0.92 PARP1 (0.39) PARP1PARP2DHODH
SCHEMBL20594635 0.86 KDM4E (0.42) DHODHKDM4EHSD17B10ALDH1A1GAA
SCHEMBL21227401 0.85 TYK2 (0.37) KDM4EHSD17B10CASP1CASP7
SCHEMBL20697405 0.84 TYK2 (0.43) PARP1PARP2DHODHKDM4EHSD17B10
SCHEMBL20689398 0.84 TYK2 (0.43) PARP1PARP2DHODHKDM4EHSD17B10
SCHEMBL27354940 0.84 PARP1 (0.43) PARP1PARP2KDM4EHSD17B10ALDH1A1
SCHEMBL22498188 0.83 KDM4E (0.47) PARP1KDM4EHSD17B10ALDH1A1GAA
SCHEMBL20689365 0.82 PARP1 (0.44) PARP1DHODHKDM4EHSD17B10ALDH1A1
SCHEMBL29754548 0.82 DHODH (0.38) DHODHKDM4EHSD17B10ALDH1A1GAA
SCHEMBL30612395 0.82 KDM4E (0.52) PARP1PARP2KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062416-A1 INHIBITORS OF KIF18A AND USES THEREOF ACCENT THERAPEUTICS INC (US) 2026-03-05 — — US disclosed
WO-2024146593-A1 AROMATIC AMIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 浙江海正药业股份有限公司 2024-07-11 — — WO disclosed
WO-2024035950-A1 INHIBITORS OF KIF18A AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2024-02-15 — — WO disclosed
WO-2024035950-A1 INHIBITORS OF KIF18A AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2024-02-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062416-A1 INHIBITORS OF KIF18A AND USES THEREOF KIF18A, KIF18B, KIF5B PARP1 873/4885PARP2 1076/4885DHODH 1101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback